A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeuticsor Hospitalized Patients with COVID-19

About this Study
Sponsor Protocol ID:pending
IRB Number:2020V0226
Actively Enrolling
Interventional
Early Phase 1
October 29, 2020
Eligibility Criteria
Both Male and Female
No
No
No
Categories Click category to view its trials.
COVID-19 (Coronavirus)
Participating Locations
University Hospital
Contact Information
Contact Name: Rebekah Peacock
Phone Number: 601-815-3008
Email: rpeacock@umc.edu
Principal Investigator:Jones, Alan E, M.D.
How to participate in our Clinical Trials